Author

Gijs R. van den Brink 1

1 Department Of Gastroenterology And Hepatology, Amc Amsterdam, Amsterdam, Netherl

ARE HIGH INFLIXIMAB TROUGH LEVELS ASSOCIATED WITH IMPAIRED QUALITY OF LIFE IN IBD PATIENTS IN CLINICAL AND BIOCHEMICAL REMISSION ON INFLIXIMAB MAINTENANCE THERAPY?

Mark Lowenberg, Laura Vos, Cyriel Y. Ponsioen, Gijs R. van den Brink, Geert R. D'Haens

ATG16L1 GENOTYPE IS ASSOCIATED WITH RESPONSE TO ANTI-TNF

Manon E. Wildenberg, Anne Christine Wilhelmina Vos, Johannan Frank Brandse, Geert R. D'Haens, Gijs R. van den Brink, Alon Levin, Jessica R. de Bruyn, Gijs R. van den Brink

Closing remarks

Gijs R. van den Brink, Jean-François Dufour

Diet, immunity and IBD

Gijs R. van den Brink

DISEASE LOCALIZATION DETERMINES FECAL CALPROTECTIN LEVELS IN CROHN’S DISEASE

Krisztina Barbara Gecse, Sandra van Wilpe, Hanke Brandse, Mark Lowenberg, Cyriel Y. Ponsioen, Gijs R. van den Brink, Geert R. D'Haens

EARLY APPEARANCE OF ANTIBODIES TO INFLIXIMAB PREDICTS LACK OF RESPONSE TO INFLIXIMAB INDUCTION TREATMENT IN PATIENTS WITH MODERATE-SEVERE ULCERATIVE COLITIS

Gijs R. van den Brink, Mark Lowenberg, Cyriel Y. Ponsioen, Geert R. D'Haens

ER STRESS DEPLETES APC MUTANT INTESTINAL EPITHELIAL STEM CELLS DOWNSTREAM OF NUCLEAR BETA-CATENIN

Jooske van Lidth, Amy S. Lee, Gijs R. van den Brink, Jarom Heijmans, Mattheus Carolus Benignus Wielenga, Gijs R. van den Brink

HIGH SERUM CRP PREDICTS FASTER CLEARANCE OF INFLIXIMAB AND POOR OUTCOME IN MODERATE-SEVERE ULCERATIVE COLITIS

Gijs R. van den Brink, Desiree van der Kleij, Karien Bloem, Mark Lowenberg, Cyriel Y. Ponsioen, Ron Mathôt, Geert R. D'Haens

INDIAN HEDGEHOG IS REQUIRED FOR INTESTINAL ADENOMA FORMATION

Jarom Heijmans, Beate K.M. Lanske, Gijs R. van den Brink, Nike VJA Buller, Sanne Rosekrans, G.J.A. Offerhaus, Manon E. Wildenberg, Gijs R. van den Brink

INDUCTION OF ER STRESS IDENTIFIES POTENTIAL ESOPHAGEAL STEM CELL MARKERS

Sanne Rosekrans, Jarom Heijmans, Carl Puylaert, Jessica Westerlund, Gijs R. van den Brink

Item 1 - 10 / 60
1
2 3 4 5 6